Evan Giangrande

Assistant Professor

University of South Carolina
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (11)

Mendelian imputation is a promising method for imputing missing parental genotypes and estimating direct and indirect genetic effects. While the method has clear scientific benefits, so far there has been little reflection on its legal and ethical implications. In this perspective, we discuss these considerations and provide recommendations on transparent use of this method. We argue that imputed genotypes should be considered identifiable, personal data, and that using these data requires informed consent. We distinguish different scenarios where consent may be missing, such as an individual previously not having been contacted for consent, or a person who was contacted but did not reply or did not wish to participate. Informed consent is important across all these scenarios as it allows individuals to decide whether they want to participate in a study. In addition, transparent communication on how people’s data are used is important for public perception of science, and a failure to communicate this may contribute to mistrust. We discuss potential harmful applications of Mendelian imputation, and how robust regulatory frameworks guiding Institutional Review Boards on novel advanced methods such as Mendelian imputation are currently missing. This complicates decision making, especially when researchers argue for public interest as a lawful basis for foregoing consent. We end with a set of recommendations for (1) future genetic research projects for which Mendelian imputation will be possible; (2) research that has already been conducted using this method; and (3) the inclusion of ethical considerations in the publication of novel techniques/analyses.

Year:

2026

Year:

2026

Major depressive disorder (MDD) affects millions worldwide, yet its neurobiological underpinnings remain elusive. Neuroimaging studies have yielded inconsistent results, hindered by small sample sizes and heterogeneous depression definitions. We sought to address these limitations by leveraging the UK Biobank’s extensive neuroimaging data (n=30,122) to investigate how depression phenotyping depth influences neuroanatomic profiles of MDD. We examined 256 brain structural features, obtained from T1- and diffusion-weighted brain imaging, and nine depression phenotypes, ranging from self-reported symptoms (shallow definitions) to clinical diagnoses (deep). Multivariable logistic regression, machine learning classifiers, and feature transfer approaches were used to explore correlational patterns, predictive accuracy and the transferability of important features across depression definitions. For white matter microstructure, we observed widespread fractional anisotropy decreases and mean diffusivity increases. In contrast, cortical thickness and surface area were less consistently associated across depression definitions, and demonstrated weaker associations. Machine learning classifiers showed varying performance in distinguishing depression cases from controls, with shallow phenotypes achieving similar discriminative performance (AUC=0.807) and slightly higher positive predictive value (PPV=0.655) compared to deep phenotypes (AUC=0.831, PPV=0.456), when sensitivity was standardized at 80%. However, when shallow phenotypes were downsampled to match deep phenotype case/control ratios, performance degraded substantially (AUC=0.690). Together, these results suggest that while core white-matter alterations are shared across phenotyping strategies, shallow phenotypes require approximately twice the sample size of deep phenotypes to achieve comparable classification performance, underscoring the fundamental power-specificity tradeoff in psychiatric neuroimaging research.

Year:

2025

Mendelian imputation is a promising method for imputing missing parental genotypes and estimating direct genetic effects. While the method has clear scientific benefits, so far there has been little reflection on its legal and ethical implications. In this perspective, we discuss these considerations and provide recommendations on transparent use of this method. We argue that imputed genotypes should be considered identifiable, personal data, and that using these data requires informed consent. We distinguish different scenarios where consent may be missing, such as an individual previously not having been contacted for consent, or a person who was contacted but did not reply or did not wish to participate. Informed consent is important across all these scenarios as it allows individuals to decide whether they want to participate in a study. In addition, transparent communication on how people’s data are used is important for public perception of science, and a failure to communicate this may contribute to mistrust. We discuss potential harmful applications of Mendelian imputation, and how robust regulatory frameworks guiding Institutional Review Boards on novel advanced methods such as Mendelian imputation are currently missing. This complicates decision making, especially when researchers argue for public interest as a lawful basis for foregoing consent. We end with a set of recommendations for 1) future genetic research projects for which Mendelian imputation will be possible; 2) research that has already been conducted using this method; and 3) the inclusion of ethical considerations in the publication of novel techniques/analyses.

Year:

2025

Objectives: Birth weight is a widely used indicator of prenatal experiences in models of the developmental origins of cognitive ability across the lifespan. Methods: We modeled change in the strength of the association between birth weight and cognitive ability in a sample of twins (n = 1,501; 53.1% female; 91.1% White) followed prospectively from infancy to midlife. Results: The magnitude of the association between birth weight and cognitive ability declined exponentially from infancy (β = .59, p < .05) to midlife (β = .27, p < .05). A 1-kilogram increase in birth weight was associated with an 8.85-point increase in cognitive scores at 3 months and a 4.05-point advantage after about 2.5 years. Biometric regression models revealed that shared environmental factors accounted for the decline in the association between birth weight and cognitive ability. A small, positive within-pair association persisted into midlife. Discussion: Findings support developmental origin models of cognitive ability across the lifespan.

Year:

2025

For decades, researchers have debated whether the magnitude of the Flynn Effect—intergenerational increases in mean IQ scores—varies across cognitive domains and subdomains, and whether the Flynn Effect reflects gains in general cognitive ability (g). We conducted a cross-domain, subtest-level investigation of the Flynn Effect across middle childhood and early adolescence (ages 7-15 years, N = 1187, 89% White, 9% Black, 52% female) in longitudinal cognitive ability data collected prospectively between 1957 and 1999 using three versions of the Wechsler Intelligence Scale for Children. Results provided clear evidence of the Flynn Effect as both increases in mean IQ score across generational cohort and decreases in mean IQ across test versions. Flynn Effect magnitude differed substantially across domains and subtests. Performance IQ gains were larger than full-scale and verbal IQ gains in cohort-based analyses, but test version-based estimates showed an opposite pattern (VIQ > FSIQ > PIQ). Variance in Flynn Effect magnitude across subtests did not follow a discernible pattern. The strength of the Flynn Effect on individual subtests was not strictly proportional to each subtest’s g-loading, with performance IQ subtests showing larger increases than would be expected given their g-loadings and verbal subtests showing smaller-than-expected gains.

Year:

2025

The heritability (G) of cognitive ability increases substantially across development. However, previous studies of G x Age interaction—also known as the Wilson Effect—have not controlled for developmental changes in the reliability of cognitive assessment. Unmodeled reliability changes may bias estimates of cognitive growth and G x Age interaction, obscuring the developmental etiology of cognitive ability, but this possibility has not been explored empirically due to a lack of appropriate data and statistical methods. Using an expanded version of the Louisville Twin Study data set in which Ronald Wilson (1983) originally documented G x Age interaction, we first replicated heritability increases between ages 3 months and 15 years. Then, we examined the extent to which unmodeled reliability changes biased estimates of G x Age interaction using continuous time dynamic modeling. Our-best fitting model, which corrected for reliability differences across test battery and age, estimated that heritability increased from .26 to .55. Reliability increased substantially across development, from less than .30 in infancy to approximately .80 at age 15. Models that did not control for developmental reliability increases yielded downwardly biased estimates of cognitive growth and differentiation, G x Age interaction, developmental decreases in shared environmental effects, and increases in non-shared environmental effects. Results indicated that a re-evaluation of previous G x Age estimates may be warranted, and that future studies should control for developmental fluctuations in reliability. Our continuous time dynamic models improved estimation of developmental change in cognitive ability and can be easily adapted to other psychological constructs.

Year:

2025

The heritability (G) of cognitive ability increases substantially across development. However, previous studies of G x Age interaction—also known as the Wilson Effect—have not controlled for developmental changes in the reliability of cognitive assessment. Unmodeled reliability changes may bias estimates of cognitive growth and G x Age interaction, obscuring the developmental etiology of cognitive ability, but this possibility has not been explored empirically due to a lack of appropriate data and statistical methods. Using an expanded version of the Louisville Twin Study data set in which Ronald Wilson (1983) originally documented G x Age interaction, we first replicated heritability increases between ages 3 months and 15 years. Then, we examined the extent to which unmodeled reliability changes biased estimates of G x Age interaction using continuous time dynamic modeling. Our-best fitting model, which corrected for reliability differences across test battery and age, estimated that heritability increased from .26 to .55. Reliability increased substantially across development, from less than .30 in infancy to approximately .80 at age 15. Models that did not control for developmental reliability increases yielded downwardly biased estimates of cognitive growth and differentiation, G x Age interaction, developmental decreases in shared environmental effects, and increases in non-shared environmental effects. Results indicated that a re-evaluation of previous G x Age estimates may be warranted, and that future studies should control for developmental fluctuations in reliability. Our continuous time dynamic models improved estimation of developmental change in cognitive ability and can be easily adapted to other psychological constructs.

Year:

2025

Key Points Question Is variation in global functioning among people with schizophrenia associated with genetic differences? Findings In this genetic association study of 5991 adults with schizophrenia and 59,795 hospitalizations, polygenic scores for schizophrenia and educational attainment predicted global functioning at psychiatric admission and discharge, as well as the magnitude of functional improvement during hospitalization. Higher polygenic burden for schizophrenia was consistently associated with worse functional outcomes, including less functional improvement during hospitalization, while educational attainment polygenic score showed a more complex pattern of associations. Meaning Polygenic scores may help disentangle heterogeneity in schizophrenia functioning and course. Importance Schizophrenia is characterized by heterogeneity in disease outcomes and course. The extent to which this heterogeneity is associated with genetic variation is unclear. Objective To investigate whether polygenic scores (PGS) for schizophrenia and educational attainment are associated with global functioning during inpatient psychiatric hospitalization among patients with schizophrenia. Design, Setting, and Participants Adults with schizophrenia were recruited nationwide for the SUPER-Finland Study between 2015 and 2018. Global functioning scores recorded during hospitalizations between 1994 and 2019 were extracted from a complete, longitudinal register. Data for the current genetic association study were analyzed between May 2024 and April 2025. We used linear mixed-effects models to examine associations among PGS and global functioning at admission and discharge, as well as functional change during hospitalization. Exposures Psychiatric hospitalization and PGS for schizophrenia and educational attainment. Main Outcomes and Measures Admission global functioning, discharge global functioning, and functional change during hospitalization. Results We analyzed 117,810 global functioning scores from 59,795 hospitalizations and 5991 participants (2733 [45.62%] female, median [IQR] age = 47 [20] years). Higher schizophrenia PGS predicted lower admission global functioning ( β = −0.20; 95% CI, −0.40 to 0.00; P = .05) and discharge global functioning ( β = −0.36; 95% CI,−0.56 to −0.17; P < .001), and less functional improvement ( β = −0.31; 95% CI, −0.49 to −0.14; P < .001). Higher educational attainment PGS predicted greater functional improvement ( β = 0.20; 95% CI, 0.03 to 0.37; P = .02) but worse admission global functioning ( β = −0.23; 95% CI, −0.43 to −0.04; P = .02). Conclusions and Relevance Higher genetic liability for schizophrenia is associated with worse global functioning across psychiatric hospitalization, including less functional improvement. Integrating PGS and clinically relevant, longitudinal disease outcomes may help parse heterogeneity in schizophrenia prognosis and course.

Year:

2025

Year:

2024

Year:

2024

Collaborators (16)

Jordan Smoller

Professor

Massachusetts General Hospital

UNITED STATES
View details

Chris Kennedy

Researcher

Massachusetts General Hospital

UNITED STATES
View details

Deborah Finkel

Professor

Jönköping University

SWEDEN
View details

Margot van de Weijer

University of Amsterdam

NETHERLANDS
View details

Tian Ge

Broad Institute

UNITED STATES
View details

Deborah Davis

Professor

University of Louisville

UNITED STATES
View details

Benjamin Neale

Associate Professor

Broad Institute

UNITED STATES
View details

Christopher Beam

Associate Professor

University of Southern California

UNITED STATES
View details

Aarno Palotie

University of Helsinki

FINLAND
View details

Markku Lähteenvuo

Niuvanniemi Hospital

FINLAND
View details

Olli Pietilainen

Group Leader

University of Helsinki

FINLAND
View details

Chloe Hudson

Assistant Professor

Virginia Tech

UNITED STATES
View details

Paul S. Appelbaum

Research Scientist and Director

New York State Psychiatric Institute

UNITED STATES
View details

Charles C. Driver

University of Zurich

SWITZERLAND
View details

Lucas Matthews

New York State Psychiatric Institute

UNITED STATES
View details

Jaana Suvisaari

Research Professor

National Institute for Health and Welfare

FINLAND
View details